The Street Sweeper

About the Author The Street Sweeper

Sonya Colberg joined TheStreetSweeper in early 2012 as a senior investigative reporter after racking up an impressive pile of journalism awards for her past work at two major daily newspapers. For example, Colberg recently won top honors – recognized by the Society of Professional Journalists and the Associated Press alike – for her performance in the tough investigative reporting field. During her long and decorated career, she has walked away with major prizes for her in-depth coverage of business and healthcare as well. A fearless reporter with incredible writing skills, Colberg has now teamed up with Melissa Davis – another award-winning journalist who serves as senior editor of TheStreetSweeper – to deliver hard-hitting coverage of risky stocks to the investment community.

Glu Mobile Inc. (GLUU) From A Bearish Perspective

Her stilettos flashing and iPhone snapping selfies, Kim Kardashian is racing out in front, with Deer Hunter close behind, and Racing Rivals bringing …

La Jolla Pharmaceutical Company (LJPC): Lost Opportunity, Insider Questions Should Chop Valuation By Well Over Half

by Sonya Colberg The market has recently blasted La Jolla Pharmaceutical Company (NASDAQ:LJPC) shares to mystifying levels, thanks primarily to insider buying. But that …

Kornit Digital Ltd: Top Competitor Acquisition Signals KRNT’s Vast Risks, Overvaluation

TheStreetSweeper alerts investors to the latest negative event subsequent to our July 6 report on the massive risks facing Kornit Digital Ltd (NASDAQ:KRNT) – …

Uranium Energy Corporation (UEC): The Bad News Buried In The Recent Sale

Uranium Energy Corp. (NYSEMKT:UEC) is digging all the love it’s getting from the market right now.

Valuing Northwest Biotherapeutics, Inc From A Bearish Perspective

TheStreetSweeper issues an alert about a desperate situation occurring at Northwest Biotherapeutics, Inc (NASDAQ:NWBO). The biotech’s recently hyped effort – early Phase 1 …

Plasmatech Biopharmaceuticals Inc (PTBI): “News” On Orphan Drug Status Is Hyped Up To Raise Stock Price

Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI) rocketed on “news” that the FDA granted orphan drug status to its newly acquired gene therapy products. But PTBI’s …

Chanticleer Holdings Inc (HOTR): Turning Down The Fire

  Chanticleer Holdings Inc (NASDAQ:HOTR) has recently been scorching hot. Yet its business plan is so cold, it could have frozen the raunchy …

Anthera Pharmaceuticals Inc (ANTH): Another Cash-Poor, Bubbly Biotech About To Blow Apart

  Anthera Pharmaceuticals Inc (NASDAQ:ANTH) investors may have forgotten its 2013 drug study scandal that set the scientific community spinning, as well as …

Clean Diesel Technologies, Inc. (CDTI): Burning Cash, Emitting Spotted History and Financials

  If a company’s business is so flimsy that optimistic analysts must resort to commenting on the company’s “body language” for good results, …

QuinStreet Inc (QNST): A Wreck Is Right Around The Corner

  One minute, QuinStreet Inc (NASDAQ:QNST) was merrily redirecting traffic from Google searches and picking up millions along the way in exchange for …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts